| ［1］ Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective［J］. Oncologist,2010,15 (Suppl 4):5-13.［2］ Comunale MA, Lowman M, Long RE, et al. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma［J］. J Proteome Res,2006,5(2):308-315.［3］ Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications［J］.Clin Chim Acta, 2008, 395(1-2):19-26.［4］ Dai Z, Fan J, Liu Y, et al. Identification and analysis of alpha 1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach［J］. Electrophoresis, 2007, 28(23): 4382-4391.［5］ Kundranda MN, Henderson M, Carter KJ,et al.The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms［J］. Cancer Res, 2005, 65(2):499-506.［6］ Lee HB, Yoo OJ, Ham JS, et al. Serum alphal-antitrypsin in patients with hepatocellular carcinoma［J］. Clin Chim Acta, 1992,206(3):225-230.［7］ Rolny C, Mazzone M, Tugues S,et al.HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PIGF［J］.Cancer Cell, 2011, 19(1):31-44.［8］ Ganfornina MD, Do Carmo S, Lora JM, et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress［J］. Aging Cell, 2008,7(4):506-515.［9］ Zhang S, Janciauskiene S.Multi-functional capability of proteins: alpha1-antichymotrypsin and the correlation with Alzheimer′s disease［J］. J Alzheimers Dis, 2002,4(2):115-122.［10］ 张 磐,范学工,Haichao Wang.暴发性肝衰竭小鼠肝组织胎球蛋白A的变化及其病理学意义［J］.中华肝脏病杂志,2008,16(6):440-444.［11］ Armstrong PB.Role of α2-macroglobulin in the immune responses of invertebrates［J］. ISJ, 2010,7(2): 165-180.［12］ Gravagna P, Gianazza E, Arnaud P,et al.Modulation of the immune response by plasma protease inhibitors Ⅲ. Alpha 1-antichymotrypsin inhibits human natural killing and antibody-dependent cell-mediated cytotoxicity［J］. J Reticuloendothel Soc,1982,32(2):125-130.［13］ Aso H, Tamura K, Rose MT, et al.Effect of alpha 1-acidic glycoprotein in the ascitic fluid of cancer patients on human NK cells: selective suppression of interferon-induced NK activation［J］. Inflammation, 1999, 23(2):117-129.［14］ Mehta AS, Long RE, Comunale MA, et al.Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis［J］. J Virol, 2008,82(3):1259-1270.［15］ Schroeder HW Jr, Cavacini L.Structure and function of immunoglobulins［J］. J Allergy Clin Immunol, 2010,125(2 Suppl 2):S41-S52.［16］ Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans［J］.Diabetes Care, 2006, 29(4):853-857.［17］ McClain DA, Lubas WA, Cooksey RC, et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia［J］. Proc Natl Acad Sci USA, 2002, 99(16):10695-10699.［18］ Knezevic A, Gornik O, Polasek O, et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans［J］.Glycobiology, 2010, 20(8):959-969.［19］ Azuma Y, Murata M, Matsumoto K. Alteration of sugar chains on alpha1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro［J］.Clin Chim Acta, 2000, 294(1-2):93-103.［20］ Kalabay L, Gráf L, Vrs K, et al.Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores［J］. BMC Gastroenterol, 2007,7:15.［21］ Kang X, Sun L, Guo K, et al. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS［J］.J Cancer Res Clin Oncol, 2010,136(8):1151-1159.［22］ Vanderschaeghe D,Laroy W,Sablon E,et al.Glyco-FibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics［J］. Mol Cell Proteomics, 2009, 8(5):986-994.［23］ Fang M, Zhao YP, Zhou FG,et al.N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma［J］.Int J Cancer, 2010,127(1):148-159.［24］ 王华梁.甲胎蛋白异质体的检测及临床应用［J］.上海医学检验杂志,2001,16 (2):116-118.［25］ 季 君, 顾 星, 高致远,等.凝集素捕获微量离心柱法检测甲胎蛋白异质体在原发性肝癌中的应用评价［J］. 检验医学, 2011,26(4):256-259.［26］ Comunale MA, Wang M, Hafner J, et al.Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma［J］. J Proteome Res, 2009, 8(2):595-602.［27］ Debruyne EN, Vanderschaeghe D, Van Vlierberghe H,et al.Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients［J］. Clin Chem, 2010, 56(5):823-831.［28］ Comunale MA, Rodemich-Betesh L, Hafner J,et al.Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma［J］. PLoS One, 2010, 5(8):e12419.［29］ Hashimoto S, Asao T, Takahashi J, et al. Alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis［J］. Cancer, 2004,101(12):2825-2836.［30］ Norton PA, Comunale MA, Krakover J, et al. N-linked glycosylation of the liver cancer biomarker GP73［J］. J Cell Biochem, 2008,104(1):136-149. |
